A class action lawsuit has been filed against CVRx alleging the company engaged in illegal sales practices, including kickbacks and false claims to government health programs, to boost revenue. The complaint claims CVRx's reported revenue was partly from unlawful conduct, making it unsustainable and exposing the company to legal risks. Investors who bought CVRx securities between July 25, 2023, and August 6, 2026, may join the lawsuit and seek damages. The lead plaintiff deadline is January 8, 2027.
The class action lawsuit against CVRx provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 11, 2026 01:11 WIB: out of 150 priced US health stocks, 39 rose and 110 fell today. Notable movers include Canopy Growth Corp (CGC) at USD 0.59 with a -5.27% change, Ionis Pharmaceuticals (IONS) at USD 29.42 with a -5.10% change, and Sana Biotechnology (SANA) at USD 2.34 with a -5.07% change.
As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...
EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...
The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...
Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...
Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...
